CHARLES SCHWAB INVESTMENT MANAGEMENT INC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$652,938
+22.4%
170,036
+4.5%
0.00%
Q2 2023$533,482
+480.2%
162,647
+356.4%
0.00%
Q1 2023$91,946
+154.1%
35,638
+83.2%
0.00%
Q4 2022$36,181
+0.5%
19,4520.0%0.00%
Q3 2022$36,000
-14.3%
19,4520.0%0.00%
Q2 2022$42,000
-32.3%
19,4520.0%0.00%
Q1 2022$62,000
-1.6%
19,4520.0%0.00%
Q4 2021$63,000
-4.5%
19,4520.0%0.00%
Q3 2021$66,000
-14.3%
19,4520.0%0.00%
Q2 2021$77,000
-83.9%
19,452
-83.6%
0.00%
Q1 2021$478,000
+91.2%
118,778
+10.1%
0.00%
Q4 2020$250,000
-55.4%
107,882
+10.7%
0.00%
Q3 2020$560,000
-24.7%
97,439
-3.4%
0.00%
Q2 2020$744,000
+1228.6%
100,851
+442.9%
0.00%
Q1 2020$56,000
-28.2%
18,5780.0%0.00%
Q4 2019$78,000
-42.6%
18,578
-74.6%
0.00%
Q2 2019$136,000
-24.0%
73,229
-27.2%
0.00%
Q1 2019$179,000
+26.1%
100,598
+72.0%
0.00%
Q4 2018$142,000
-58.1%
58,471
-2.0%
0.00%
Q3 2018$339,000
+24.2%
59,687
+70.8%
0.00%
Q2 2018$273,000
+12.3%
34,940
+1.9%
0.00%
Q1 2018$243,000
+19.7%
34,295
+67.2%
0.00%
Q4 2017$203,000
+62.4%
20,510
+41.4%
0.00%
Q3 2017$125,000
-18.3%
14,5000.0%0.00%
Q2 2017$153,00014,5000.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders